I do agree that PFE is undervalued now, especially with the 4% + div. and the merger savings in the billions. I own PFE and SGEN as my biggest investments as of today.
SGEN price/volume action in the last 15 minutes tell me that we are at the bottom for this one too.
This has been going on in the oil and gas segment for years. They're a dime a dozen especially in Texas. It's almost as bad as the corrupt china stock scams where everyone lost millions. Trading stocks is at your own risk so no one is held accountable as we all witnessed in the mortgage meltdown. We eagerly give cash to those who are only interested in their own agendas. Happy trading; and remember "always take your profits". You can always re-enter at a lower price and do it all again. Older and wiser than the punks.
Finding a legitimate way to do a Madoff was not hard to do. Madoff made one mistake and that was not buying any stock or funds with the money so he had no paper trail. He just spent the money. Buying several shares of stock in the same sector and running the price up with positive news and share purchases plastered all over the news is how it's done. The herd will follow by word of mouth and a couple of wins along the way. You can get on the board of a few of them but mostly you stay low and run up the share price, bail out, and do another one with no involvement with the board so there is no lock up on the sale date. After the selling of shares the bag holders lose when the shares get under a buck and you do another IPO and announce your purchases. REPEAT-The herd runs it up so you can profit. Brilliant
They also bougth more BCRX in the 6' after the huge fall from 15$.They try to average down their failures.
Wow, lots of new posters on this board. Thinking of dipping my toes in ACAD for the next run-up. Will check the action out tomorrow. If it's an up day, I will pull the trigger on Friday if it holds at the close on Thurs. I don't want any head fake.
Now I'm term14? Hey, hope the day traders are hauling a_ _ with this stock. 3 bucks turnaround is great. I'm out of this but always like to see these huge swings. Way to go if you made some quick cash.
Credit Suisse analyst Kennen MacKay issued a report today on SGEN's CD-33A that predicts a measure of success in 1L AML in elderly, high risk patients vis-a-vis Roche/AbbVie’s venetoclax:
"ORR Rates Similar but SGN-CD33A May Have Safety Edge: In data to date, we note that venetoclax has achieved comparable response rates vs. SGN33A with similar safety profiles in this population (see Figure 1). While the FDA’s breakthrough designation likely expedites venetoclax’s approval, we see room for multiple players and note SGN-CD33A avoids tumor lysis syndrome, which could complicate venetoclax dosing. We see venetoclax’s oral dosing as an advantage, but note dose-related tumor lysis syndrome could necessitate a REMS program, including potential hospitalization/monitoring during dose up-titration. This could potentially
dissuade physicians and patients given logistical hurdles. Hence, we maintain our SGN-CD33A assumptions of a 2020 launch with 45% peak market share."
Seven grayed out/ignored posts in a row. I take it that the multi-aliased sanity-challenged troll known as fstout57/term14/quadhole/quadholes/rickarooski/etc. is talking to himself again.